The Interplay between Inflammation, Anti-Angiogenic Agents, and Immune Checkpoint Inhibitors: Perspectives for Renal Cell Cancer Treatment - Brighi, N; Farolfi, A; Conteduca, V (Cancers (Basel), 2019)
et al.